This document addresses questions on how to demonstrate comparability for gene and cell-based medicinal products following change to the manufacturing process or due to introduction of additional manufacturing sites.
Keywords: Gene therapy medicinal products; cell-therapy and tissue engineering.
Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to the European Medicines Agency instead.